dr. herbst on the bevacizumab biosimilar in lung cancer
Published 6 years ago • 259 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
1:49
dr. herbst on the impact of frontline immunotherapy in lung cancer
-
1:01
dr. herbst on the international lung cancer congress
-
7:40
bevacizumab in nonsquamous lung cancer
-
1:56
dr. herbst on advances of immunotherapy in lung cancer
-
0:58
dr. herbst on immunotherapy in lung cancer
-
1:22
dr. herbst on immune resistance in lung cancer
-
2:02
dr. herbst on the development of biomarkers for lung cancer
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
1:35
dr. herbst on immuno-oncology combinations in lung cancer
-
1:42
dr. herbst on tmb as a biomarker in nsclc
-
2:15
dr. herbst on the next generation of lung cancer trials
-
1:11
dr. herbst on screening studies at the upcoming lung cancer congress
-
1:18
dr. herbst on next-generation agents in nsclc
-
1:02
dr. herbst on pd-1 inhibitors in lung cancer
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
1:35
dr. herbst on promising immunotherapy combinations in nsclc
-
1:03
dr. herbst on combination of nivolumab and ipilimumab in patients with nsclc